Palisade Bio Inc. (PALI) Announces Exercise for $2.5M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Palisade Bio Inc. (PALI) Announces Exercise for $2.5M

Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million

January 30, 2024 9:25 AM EST

Carlsbad,CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.  (Nasdaq: PALI) (Palisade or the Company), a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal (GI) diseases, today announced an agreement between the Company and several accredited investors to exercise certain existing warrants (the Existing Warrants) to purchase up to an aggregate of 3,413,286 shares of common stock. The Existing Warrants had initial exercise prices of... More